Bank of New York Mellon’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $896K | Buy |
|
|||||
|
2025
Q2 | $820K | Buy |
|
|||||
|
2025
Q1 | $786K | Sell |
|
|||||
|
2024
Q4 | $838K | Sell |
|
|||||
|
2024
Q3 | $963K | Sell |
|
|||||
|
2024
Q2 | $1.46M | Buy |
|
|||||
|
2024
Q1 | $975K | Sell |
|
|||||
|
2023
Q4 | $1.08M | Buy |
|
|||||
|
2023
Q3 | $1.08M | Sell |
|
|||||
|
2023
Q2 | $3.44M | Buy |
|
|||||
|
2023
Q1 | $3.47M | Buy |
|
|||||
|
2022
Q4 | $3.74M | Sell |
|
|||||
|
2022
Q3 | $7.54M | Buy |
|
|||||
|
2022
Q2 | $6.72M | Sell |
|
|||||
|
2022
Q1 | $14.5M | Sell |
|
|||||
|
2021
Q4 | $23.1M | Buy |
|
|||||
|
2021
Q3 | $22.1M | Buy |
|
|||||
|
2021
Q2 | $23.5M | Buy |
|
|||||
|
2021
Q1 | $8.79M | Buy |
|
|||||
|
2020
Q4 | $7.62M | Sell |
|
|||||
|
2020
Q3 | $5.85M | Sell |
|
|||||
|
2020
Q2 | $7.13M | Buy |
|
|||||
|
2020
Q1 | $6.22M | Sell |
|
|||||
|
2019
Q4 | $10.1M | Buy |
|
|||||
|
2019
Q3 | $8.04M | Buy |
|
|||||
|
2019
Q2 | $8.38M | Sell |
|
|||||
|
2019
Q1 | $11.1M | Sell |
|
|||||
|
2018
Q4 | $16.5M | Buy |
|
|||||
|
2018
Q3 | $13.6M | Buy |
|
|||||
|
2018
Q2 | $4.08M | Buy |
|
|||||
|
2018
Q1 | $3.45M | Buy |
|
|||||
|
2017
Q4 | $3.04M | Buy |
|
|||||
|
2017
Q3 | $3.57M | Buy |
|
|||||
|
2017
Q2 | $3.2M | Buy |
|
|||||
|
2017
Q1 | $2.6M | Buy |
|
|||||
|
2016
Q4 | $2.96M | Buy |
|
|||||
|
2016
Q3 | $2.94M | Sell |
|
|||||
|
2016
Q2 | $2.18M | Sell |
|
|||||
|
2016
Q1 | $1.67M | Buy |
|
|||||
|
2015
Q4 | $1.75M | Sell |
|
|||||
|
2015
Q3 | $2.33M | Sell |
|
|||||
|
2015
Q2 | $2.94M | Buy |
|
|||||
|
2015
Q1 | $2.05M | Buy |
|
|||||
|
2014
Q4 | $3.06M | Sell |
|
|||||
|
2014
Q3 | $6.78M | Sell |
|
|||||
|
2014
Q2 | $10.6M | Buy |
|
|||||
|
2014
Q1 | $8.33M | Buy |
|
|||||
|
2013
Q4 | $2.24M | Sell |
|
|||||
|
2013
Q3 | $2.81M | Buy |
|
|||||
|
2013
Q2 | $1.3M | Buy |
|